Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination.

MLA

Robichaud, Julie, et al. “Systemic Capillary Leak Syndrome after ChAdOx1 NCOV-19 (Oxford-AstraZeneca) Vaccination.” Canadian Medical Association Journal (CMAJ), vol. 193, no. 34, Aug. 2021, pp. E1341–44. EBSCOhost, https://doi.org/10.1503/cmaj.211212.

APA

Robichaud, J., Côté, C., & Côté, F. (2021). Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination. Canadian Medical Association Journal (CMAJ), 193(34), E1341–E1344. https://doi.org/10.1503/cmaj.211212

Chicago

Robichaud, Julie, Catherine Côté, and Fanny Côté. 2021. “Systemic Capillary Leak Syndrome after ChAdOx1 NCOV-19 (Oxford-AstraZeneca) Vaccination.” Canadian Medical Association Journal (CMAJ) 193 (34): E1341–44. doi:10.1503/cmaj.211212.